New Psychedelic Drug Stock To Debut After Upsized IPO Prices At High End

·

·

New Psychedelic Drug Stock To Debut After Upsized IPO Prices At High End

Atai Life Sciences (ATAI), a backer of psychedelic-drug developers, will start trading Friday, making it the latest such company to hit a major exchange as it tries to bring hallucinogens to the world of therapeutics. The Germany-based company, backed by …
See Original Article

Big Tech has a battle ahead over antitrust regulation — and it's going to get messy

Lina Khan speaking into a microphone at a congressional hearing. Lina Khan, who has been a strong advocate for breaking up Big Tech companies, was recently appointed as chair of the FTC …
See Original Article

Indian shares snap four straight weeks of gains on Fed's hawkish turn

BENGALURU, June 18 (Reuters) – Indian shares ended flat on Friday as losses in metal stocks cancelled out gains in financials, with the Nifty 50 and the Sensex marking their first week of losses in five as the U.S. central bank’s hawkish turn weighed on …
See Original Article

Early Signs of Lung Cancer and Why Screening Is Important

The location of the tumor may make a difference, says Dr. Mara Antonoff, associate professor of thoracic and cardiovascular surgery at the University of Texas MD Anderson Cancer Center in Houston. A tumor located closer to the main airways may cause early …
See Original Article

Big Oil Takes a Beating, but Its Investors Are Riding High

While major oil companies have been losing public battles over climate change, energy stocks and oil prices are soaring.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.